A U.S. appeals court on Friday rejected a novel strategy adopted by drug company Allergan PLC to shield patents from review by an administrative court by transferring them to a Native American tribe.
from Reuters: U.S. https://ift.tt/2uDu6PX
//
Monday 23 July 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment